Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,13 USD | +3,90 % | +15,76 % | +51,06 % |
Resumen de negocios
Número de empleados: 83
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Mental Health Innovations
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +34,76 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States and Germany
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +34,76 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Florian Brand
CEO | Chief Executive Officer | 37 | 01/06/18 |
Srinivas Rao
FOU | Founder | 55 | 01/06/18 |
Anne Johnson
DFI | Director of Finance/CFO | - | 01/01/21 |
Kevin Craig
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Arvind Tewari
COO | Chief Operating Officer | 39 | 01/01/21 |
Frank Stegert
CIO | Chief Investment Officer | 41 | - |
Samantha Bender
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Chief Tech/Sci/R&D Officer | 55 | 01/01/20 | |
Chris Lee
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Michael Raven
COO | Chief Operating Officer | - | 01/01/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 57 | 01/01/21 |
Founder | 46 | 01/06/18 | |
Amir Kalali
BRD | Director/Board Member | 58 | - |
Andrea Smiley
BRD | Director/Board Member | 56 | 01/01/21 |
Jason Camm
BRD | Director/Board Member | 35 | 01/01/22 |
Michael Auerbach
BRD | Director/Board Member | 48 | 01/01/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 166 026 396 | 149 440 170 ( 90,01 %) | 0 | 90,01 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
INTELGENX TECHNOLOGIES CORP. 21.36% | 37 300 000 | 21.36% | 6 564 800 $ |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. |
Pharmaceuticals: Major
|
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+51,77 % | 343 M | |
+27,62 % | 42,68 mil M | |
-3,05 % | 42,4 mil M | |
+45,32 % | 40,04 mil M | |
-6,20 % | 28,31 mil M | |
+7,16 % | 24,94 mil M | |
-20,97 % | 18,96 mil M | |
+28,61 % | 12,3 mil M | |
-2,39 % | 11,95 mil M | |
-1,82 % | 11,55 mil M |
- Bolsa de valores
- Acciones
- Acción ATAI
- Empresa Atai Life Sciences N.V.